Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

LIDOCAINE 4% CREAM

Lidocaine 4%
$0.4281per GM
OTC

Strength

4 g/100g

Manufacturer

Rugby Laboratories

NDC

00536135795

Classification

Generic

Dosage Form

CREAM

Route

TOPICAL

Last Updated

4/22/2026

Active Ingredients

LIDOCAINE

Approval Type

OTC MONOGRAPH DRUG

FDA Application

M017

On Market Since

3/2/2022

Pharmacological Classes

Amide Local Anesthetic
Amides
Antiarrhythmic
Local Anesthesia

Price History

1W

0.0%

1M

-3.2%

3M

-1.8%

6M

-6.7%

1Y

-10.1%

3Y

N/A

5Y

N/A

All

+8.5%

Generic Alternatives

1 alternative • Same active ingredient

LIDOCAINE 4% CREAM
Generic
83720052301•Oncor Pharmaceuticals
$0.5401
+26% more

Related Drugs

Same classification

BURN RELIEF 0.5% SPRAY
Generic
70000062401•Cardinal Health
$0.0276
per GM
BURN RELIEF 0.5% SPRAY
Generic
46122055528•AmerisourceBergen
$0.0283
per GM
SULFAMETHOXAZOLE-TMP SS TABLET
Generic
60687060365•American Health Packaging
$0.0385
per EA
SULFAMETHOXAZOLE-TMP SS TABLET
Generic
50268072815•AvPAK
$0.0394
per EA
SULFAMETHOXAZOLE-TMP SS TABLET
Generic
53746027105•Amneal Pharmaceuticals of New York LLC
$0.0394
per EA
SULFAMETHOXAZOLE-TMP SS TABLET
Generic
57237023201•Rising Pharma Holdings Inc.
$0.0394
per EA
SULFAMETHOXAZOLE-TMP SS TABLET
Generic
57237023205•Rising Pharma Holdings Inc.
$0.0394
per EA
SULFAMETHOXAZOLE-TMP SS TABLET
Generic
62135089718•Chartwell RX LLC
$0.0394
per EA
SULFAMETHOXAZOLE-TMP SS TABLET
Generic
62135089790•Chartwell RX LLC
$0.0394
per EA
SULFAMETHOXAZOLE-TMP SS TABLET
Generic
65162027110•Amneal Pharmaceuticals LLC
$0.0394
per EA

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy